Keller SM - Search Results

1

The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer.

Keller SM, Vangel MG, Adak S, Wagner H, Schiller JH, Herskovic A, Komaki R, Perry MC, Marks RS, Livingston RB, Johnson DH. Keller SM, et al. Lung Cancer. 2002 Sep;37(3):303-9. doi: 10.1016/s0169-5002(02)00103-4. Lung Cancer. 2002. PMID: 12234700 Clinical Trial.

2

Blood transfusion and lung cancer recurrence.

Keller SM, Groshen S, Martini N, Kaiser LR. Keller SM, et al. Cancer. 1988 Aug 1;62(3):606-10. doi: 10.1002/1097-0142(19880801)62:3<606::aid-cncr2820620327>3.0.co;2-q. Cancer. 1988. PMID: 3390797

3

Surgical treatment of non-small-cell lung cancer.

Keller SM. Keller SM. Mt Sinai J Med. 1995 May;62(3):198-203. Mt Sinai J Med. 1995. PMID: 7616974 Review. No abstract available.

4

Treatment of intrathoracic recurrent non-small-cell lung cancer.

Keller SM. Keller SM. Semin Oncol. 1993 Oct;20(5):446-50. Semin Oncol. 1993. PMID: 8211193 Review. No abstract available.

5

High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction: results of a phase II study of the Eastern Cooperative Oncology Group.

Keller SM, Ryan LM, Coia LR, Dang P, Vaught DJ, Diggs C, Weiner LM, Benson AB. Keller SM, et al. Cancer. 1998 Nov 1;83(9):1908-16. doi: 10.1002/(sici)1097-0142(19981101)83:9<1908::aid-cncr5>3.0.co;2-6. Cancer. 1998. PMID: 9806648 Clinical Trial.

6

Adjuvant therapy of resected non-small-cell lung cancer.

Keller SM. Keller SM. Curr Opin Oncol. 2000 Mar;12(2):149-55. doi: 10.1097/00001622-200003000-00009. Curr Opin Oncol. 2000. PMID: 10750727 Review.

7

Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group.

Keller SM, Adak S, Wagner H, Johnson DH. Keller SM, et al. Ann Thorac Surg. 2000 Aug;70(2):358-65; discussion 365-6. doi: 10.1016/s0003-4975(00)01673-8. Ann Thorac Surg. 2000. PMID: 10969645 Clinical Trial.

8

A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.

Keller SM, Adak S, Wagner H, Herskovic A, Komaki R, Brooks BJ, Perry MC, Livingston RB, Johnson DH. Keller SM, et al. N Engl J Med. 2000 Oct 26;343(17):1217-22. doi: 10.1056/NEJM200010263431703. N Engl J Med. 2000. PMID: 11071672 Free article. Clinical Trial.

9

Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy.

Schiller JH, Adak S, Feins RH, Keller SM, Fry WA, Livingston RB, Hammond ME, Wolf B, Sabatini L, Jett J, Kohman L, Johnson DH. Schiller JH, et al. Among authors: keller sm. J Clin Oncol. 2001 Jan 15;19(2):448-57. doi: 10.1200/JCO.2001.19.2.448. J Clin Oncol. 2001. PMID: 11208838 Clinical Trial.

10

Complete mediastinal lymph node dissection---does it make a difference?

Keller SM. Keller SM. Lung Cancer. 2002 Apr;36(1):7-8. doi: 10.1016/s0169-5002(02)00012-0. Lung Cancer. 2002. PMID: 11891026 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters